CNFG
AGN

Creegan & Nassoura Financial Group’s Allergan plc AGN Stock Holding History

Creegan & Nassoura Financial Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$719K Buy
3,120
+425
+16% +$104K 0.84% 49
2016
Q2 		$623K Hold
2,695
– – 0.74% 53
2016
Q1 		$722K Buy
+2,695
New +$771K 0.85% 51

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Creegan & Nassoura Financial Group's AGN Position: Q3 2016 in Review

Creegan & Nassoura Financial Group increased its Allergan plc (AGN) stake by 16% in Q3 2016, buying an estimated $104K and bringing the position to 3,120 shares worth $719K. The position accounts for 0.84% of the portfolio, ranked #49.

Creegan & Nassoura Financial Group first reported a position in AGN in Q1 2016 and has held it in 3 quarters since. The position peaked at $722K in Q1 2016. 1,105 funds tracked by Wall St. Rank hold AGN as of Q3 2016.

  • Creegan & Nassoura Financial Group held 3,120 shares of Allergan plc worth $719K as of Q3 2016.
  • Creegan & Nassoura Financial Group bought 425 Allergan plc shares in Q3 2016, an estimated $104K.
  • Allergan plc made up 0.84% of Creegan & Nassoura Financial Group's portfolio in Q3 2016, its #49 holding.
  • Creegan & Nassoura Financial Group first reported a position in Allergan plc in Q1 2016 and has held it in 3 quarters since.
  • Creegan & Nassoura Financial Group's Allergan plc position peaked at $722K in Q1 2016.
  • 1,105 funds tracked by Wall St. Rank held Allergan plc as of Q3 2016.

Based on Creegan & Nassoura Financial Group's 13F filing for Q3 2016, filed 14 Nov 2016.